Why Is Sonnet BioTherapeutics Stock Trading Higher On Monday?
SONN stock surged 151% amid high trading volume. Transformation with Rorschach I creates Hyperliquid Strategies Inc. Hyperliquid will hold 12.6 million HYPE tokens valued at $583 million. SONN continues R&D for its drug SON-1010 and raises $5.5 million. Shareholders gain CVRs tied to Sonnet's legacy biotech assets.
View signal analysis